Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
Abstract Rapid-response vaccine production platform technologies, including RNA vaccines, are being developed to combat viral epidemics and pandemics. A key enabler of rapid response is having quality-oriented disease-agnostic manufacturing protocols ready ahead of outbreaks. We are the first to app...
Main Authors: | Damien van de Berg, Zoltán Kis, Carl Fredrik Behmer, Karnyart Samnuan, Anna K. Blakney, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00322-7 |
Similar Items
-
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
by: Zoltán Kis, et al.
Published: (2021-12-01) -
Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. <i>Vaccines</i> 2021, <i>9</i>, 3
by: Zoltán Kis, et al.
Published: (2021-03-01) -
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
by: Alexandra J. Spencer, et al.
Published: (2021-05-01) -
RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
by: Jonas B. Sandbrink, et al.
Published: (2020-12-01) -
Techno-Economic Assessment of Cell-Free Synthesis of Monoclonal Antibodies Using CHO Cell Extracts
by: Vaishali Thaore, et al.
Published: (2020-04-01)